A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Uwe Freudenberg - , TUD Dresden University of Technology (Author)
  • Andreas Hermann - , TUD Dresden University of Technology (Author)
  • Petra B. Welzel - , TUD Dresden University of Technology (Author)
  • Katja Stirl - , TUD Dresden University of Technology (Author)
  • Sigrid C. Schwarz - , Leipzig University (Author)
  • Milauscha Grimmer - , TUD Dresden University of Technology (Author)
  • Andrea Zieris - , TUD Dresden University of Technology (Author)
  • Woranan Panyanuwat - , TUD Dresden University of Technology (Author)
  • Stefan Zschoche - , TUD Dresden University of Technology (Author)
  • Dorit Meinhold - , TUD Dresden University of Technology (Author)
  • Alexander Storch - , TUD Dresden University of Technology (Author)
  • Carsten Werner - , Center for Regenerative Therapies Dresden, Chair of Biofunctional Polymer Materials, Max Bergmann Center of Biomaterials Dresden (Author)

Abstract

Biofunctional matrices for in vivo tissue engineering strategies must be modifiable in both biomolecular composition and mechanical characteristics. To address this challenge, we present a modular system of biohybrid hydrogels based on covalently cross-linked heparin and star-shaped poly(ethylene glycols) (star-PEG) in which network characteristics can be gradually varied while heparin contents remain constant. Mesh size, swelling and elastic moduli were shown to correlate well with the degree of gel component cross-linking. Additionally, secondary conversion of heparin within the biohybrid gels allowed the covalent attachment of cell adhesion mediating RGD peptides and the non-covalent binding of soluble mitogens such as FGF-2. We applied the biohybrid gels to demonstrate the impact of mechanical and biomolecular cues on primary nerve cells and neural stem cells. The results demonstrate the cell type-specific interplay of synergistic signaling events and the potential of biohybrid materials to selectively stimulate cell fate decisions. These findings suggest important future uses for this material in cell replacement based-therapies for neurodegenerative diseases.

Details

Original languageEnglish
Pages (from-to)5049-5060
Number of pages12
JournalBiomaterials
Volume30
Issue number28
Publication statusPublished - Oct 2009
Peer-reviewedYes

External IDs

PubMed 19560816
ORCID /0000-0003-0189-3448/work/162347712

Keywords

Keywords

  • Biohybrid material, Cell replacement/implantation, Neural stem cells